Without standard definition, long COVID remains a puzzle
Long COVID has been observed clinically for 5 years, but no standard definition exists, meaning wide variations exist in the...
Month: August 2025
Financial impact of long COVID can linger for years, study finds
A multicenter cohort study today in JAMA Network Open finds that worse financial outcomes associated with long COVID (LC) are sustained for...
.jpg "Virologist network reaffirms support for mRNA vaccine platform")
Virologist network reaffirms support for mRNA vaccine platform
An international virologist group representing more than 80 research labs across more than 40 countries yesterday reaffirmed their support for...
A recent common cold may nearly halve risk of COVID-19, study suggests
Jennifer Oosthuizen / CDC A study in Israel confirms antibiotic use as a major risk factor for Clostridioides difficile infection...
COVID pandemic disrupted progress in routine child, teen vaccination rates, data suggest
A study published today in Pediatrics shows that since the COVID-19 pandemic began, routine childhood and adolescent vaccination has fallen off...
Study: Kidney-transplant recipients benefit from COVID-19 vaccination
Jennifer Oosthuizen / CDC A study in Israel confirms antibiotic use as a major risk factor for Clostridioides difficile infection...
Immunologic study shows rebound of other viruses after COVID measures lifted
The lifting of COVID-19 prevention measures such as masking and social distancing, which also tamped down the circulation of other...
US COVID activity gains more steam
iStock US adults with long COVID had higher rates of additional hospitalization in the 6 months after acute infection compared...
Study examines impact of long COVID on healthcare use
iStock US adults with long COVID had higher rates of additional hospitalization in the 6 months after acute infection compared...
Study: mRNA COVID vaccines cost-effective for US seniors, and under some scenarios, younger adults
Today in JAMA Network Open, University of Michigan-led research suggests that the US 2023-24 mRNA COVID-19 vaccines were cost-effective for people...